Wholomics

Wholomics is a biotech company that revolutionizes early cancer detection with a state-of-the-art metabolomics-based Multi-Cancer Early Detection (MCED) test. They combine powerful AI with advanced liquid biopsy technology to identify cancer at its earliest stages, even before symptoms appear. Their mission is to make early cancer detection accessible and affordable, ultimately improving patient outcomes and saving lives.